SCHEMBL19786612

SCHEMBL19786612

c1ccc(-c2nc(-n3c4c5ccccc5ccc4c4c5c6ccccc6n(-c6ccccc6)c5c5ccccc5c43)nc3oc4ccccc4c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HPGD P15428 2/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.32
POLB P06746 2/20 0.32
MEN1 O00255 1/20 0.32
MAPK1 P28482 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32
KMT2A Q03164 1/20 0.32
PTPN11 Q06124 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19246646 0.87 SMN1; SMN2 (0.39) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL19246251 0.87 SMN1; SMN2 (0.41) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL19246322 0.85 SMN1; SMN2 (0.39) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL22199937 0.85 SMN1; SMN2 (0.41) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL22652360 0.84 L3MBTL1 (0.38) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL19786334 0.84 ABCG2 (0.31) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL21431910 0.83 ALDH1A1 (0.43) LMNAALDH1A1NPSR1HPGDHTT
SCHEMBL19046678 0.83 SMN1; SMN2 (0.34) SMN1; SMN2LMNAALDH1A1CYP1A2CYP2C9
SCHEMBL19163142 0.82 TDP1 (0.30) L3MBTL1TDP1
SCHEMBL19786542 0.82 KIF11 (0.34) LMNAALDH1A1NPSR1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 SMN1; SMN2 1781/4885LMNA 2919/4885ALDH1A1 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.